• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.03% Nasdaq Up 1.29%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    15.99 Down 0.32(1.96%) May 1, 4:00PM EDT
    |After Hours : 16.25 Up 0.26 (1.63%) May 1, 4:57PM EDT
    Add to Portfolio
    Prev Close:16.31
    Open:16.50
    Bid:15.01 x 300
    Ask:16.50 x 200
    1y Target Est:38.67
    Beta:3.513
    Next Earnings Date:N/A
    Day's Range:15.51 - 16.84
    52wk Range:15.51 - 40.98
    Volume:413,000
    Avg Vol (3m):402,198
    Market Cap:647.32M
    P/E (ttm):N/A
    EPS (ttm):-1.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZMDown 1.96%647.32M
    GSKDown 0.39%110.58B
    NVSUp 1.52%247.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):13.58
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.55
    Quarterly EPS Est (Jun-15) :-0.68
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback